Login

Tishman Speyer Venture Breaks Into Philadelphia Biotech Market With Office Conversion Plan

Breakthrough Properties To Overhaul Aging Office Building Into High-End Life Science Space
Breakthrough Properties, a joint venture of Tishman Speyer and Bellco Capital, plans a roughly 200,000-square-foot life science building in Philadelphia. (Breakthrough Properties)
Breakthrough Properties, a joint venture of Tishman Speyer and Bellco Capital, plans a roughly 200,000-square-foot life science building in Philadelphia. (Breakthrough Properties)
CoStar News
May 16, 2022 | 10:37 P.M.

Philadelphia, long a secondary market for biotech investment, is seeing an uptick in development as investors seek to meet demand from an expanding roster of life sciences tenants on the hunt for a shrinking amount of available space.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE